Leticia M Toledo-Sherman

Title: The Innovative Contributions of Leticia M. Toledo-Sherman

Introduction

Leticia M. Toledo-Sherman, a prominent inventor based in Santa Monica, California, has made significant strides in the field of biochemistry and pharmacology. With an impressive portfolio of 17 patents, she focuses on developing innovative therapeutic compounds aimed at improving health outcomes.

Latest Patents

Among her latest patents are the "ATM kinase inhibitors and compositions and methods of use thereof," which detail specific ATM kinase inhibitors of Formula I. This patent encompasses compounds and methods that hold potential for various therapeutic applications. Furthermore, she has developed novel "Solid forms of a kynurenine-3-monooxygenase inhibitor," which involves the preparation and characterization of 6-(3-chloro-4-cyclopropoxyphenyl)pyrimidine-4-carboxylic acid (Compound I) in solid state. This patent outlines the processes for manufacture and methods for utilizing these forms of Compound I, including its salts and co-crystals.

Career Highlights

Leticia currently works at the CHDI Foundation, Inc., an organization dedicated to developing therapies for Huntington's disease. Her extensive research and development efforts at CHDI focus on creating groundbreaking pharmacological solutions that aim to alleviate debilitating symptoms associated with this neurodegenerative disorder.

Collaborations

Throughout her career, Leticia has collaborated with talented colleagues, including Celia Dominguez and Michael Edward Prime. These partnerships have allowed her to blend expertise and enhance the innovation process, leading to the successful creation of valuable therapeutic agents.

Conclusion

Leticia M. Toledo-Sherman's contributions to the field of chemistry and pharmacology are noteworthy and continue to impact the industry positively. Her innovative research and dedication to developing effective therapeutics highlight her as a key figure in contemporary scientific advancements.